ASPIRING is an international study, testing whether aspirin and clopidogrel prevent strokes, heart attacks, and death after brain haemorrhage. This study is run by the University of Edinburgh and NHS Lothian, and will include more than 4,000 people with brain haemorrhage worldwide.
Why are we ASPIRING?
Over 20 million people worldwide are living after a stroke due to bleeding in the brain, known as 'brain haemorrhage'. They are at risk of clotting or bleeding problems like heart attacks and strokes. Aspirin and clopidogrel can prevent heart attacks and strokes.
The ASPIRING study aims to produce reliable information about whether aspirin and clopidogrel help people after brain haemorrhage. The findings of ASPIRING could affect how doctors treat people with brain haemorrhage in everyday medical practice worldwide in the future.
Find out more
You can find out more including how to register your interest in the study by visiting the ASPIRING website (an external website hosted by University of Edinburgh)
Watch the information video
You can watch this 5-minute video about the ASPIRING study.
You might find it useful to:
- View the video full screen, after pressing play, by clicking the two arrows that appear in the bottom right-hand corner.
- Watch it more than once.
- Watch it at a slower speed.
- Watch it with someone else who can pause, rewind, and discuss it with you.
- Make a note of questions you want to ask.
ASPIRING was prospectively registered on the ISRCTN registry on 15 July 2024: ISRCTN16705062.
